13 March 2015
Warner-Lambert Company, LLC v Actavis Group PTC EHF and others [2015] EWHC 485 (Pat), [2015] All ER (D) 17 (Mar)
The Patents Court made an order that guidance should be given by the National Health Service, regarding the terms to be used to describe certain patented drugs. It held that the first and third interested parties, and the first and second defendant companies, would be included in a cross-undertaking in damages to be given by the claimant.
.tmb-mov69x69.jpg?sfvrsn=e3c4b2f1_1)
